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Introduction
Among patients with end-stage kidney disease (ESKD), physical functioning (PF) is generally poor compared to healthy age-matched individuals [1] . A high level of functional dependence is common [2] . The ability to maintain a good physical condition is important for the overall quality of life [3] . Decline of physical activity after initiation of dialysis may contribute to development of frailty [2] and it is related to poor outcome such as mortality [4, 5] and hospitalizations [6] .
With aging of the dialysis population, it has become increasingly relevant to expand the knowledge on the trajectory of PF. The risk of losing functional independence rises incrementally with age [5] . To what extent patients are able to maintain their level of independence, such as activities of daily living (ADL) and PF after dialysis initiation is difficult to estimate upfront. The few longitudinal reports that focused on the trajectory of PF in dialysis patients show that overall it tends to improve directly after dialysis initiation [7] , but declines in the following months [8] . In time, decline of PF exceeds the decline associated with normal aging [9] . Identification of patients at risk for functional decline may guide preventive interventions, such as physical therapy or rehabilitation [10] . Better knowledge of the trajectory of PF may also aid in gaining realistic expectations on quality of life after dialysis initiation. Physical well-being, as an important part of quality of life, may influence decision-making in ESKD, such as initiation or withdrawal from dialysis.
In the CONvective TRAnsport STudy (CONTRAST) , in which patients were randomized to either low-flux hemodialysis or online hemodiafiltration, the majority of patients (54%) was aged over 65 years old. Physical condition was measured yearly by the PF subscale of the Kidney Disease Quality of Life-Short Form as part of Health Related Quality of Life (HRQoL). The aim of this study was to assess to what extent chronic dialysis patients are able to maintain a good physical condition over time and what the influence of age is on the trajectory of PF.
Methods

Patients and study design
The CONTRAST (NCT00205556) is a multicenter RCT, including patients from dialysis centers in The Netherlands (26 centers), Canada (two centers) and Norway (one center), which was conducted between 2004 and 2010 and compared the effects of low-flux hemodialysis with online hemodiafiltration on all-cause mortality and cardiovascular events as described elsewhere [11] . Patients were eligible if treated with hemodialysis two to three times a week, for ≥2 months, with a minimum dialysis urea single pool Kt/V ≥ 1.2 and able to understand the study procedures. Exclusion criteria were age <18 years, treatment by hemodiafiltration of high-flux hemodialysis in the 6 months preceding randomization, severe incompliance defined as non-adherence to the dialysis prescription, a life expectancy <3 months due to causes other than kidney disease and participation in another clinical trial. The study was conducted in accordance with the Declaration of Helsinki and approved by the medical ethics review boards of all participating hospitals. Written informed consent was obtained from all patients prior to enrollment [12] . For present analyses, both study arms were assessed collectively. The overall results from CONTRAST showed no benefit of HDF above HD on quality of life and on mortality risk [12, 13] .
Data collection
Baseline demographical data were collected including age, sex and educational level. Comorbidity data included diabetes mellitus, previous coronary heart disease, cerebrovascular disease, peripheral artery disease and amputation (yes/no). Other clinical characteristics included cause of kidney failure, hemodialysis dose (single pool Kt/V urea), time on dialysis, treatment time, residual renal function, blood pressure, body mass index (BMI) and smoking habit.
Enrollment in CONTRAST was up to 31 December 2009 and follow-up ended at 31 December 2010. All participants were followed for transplantation, hospitalization and death. So for limited number of participants only 1 year of follow-up was presented, as they were censored after 1 year. We designed CONTRAST such that when a participant received a renal transplant, information on quality of life was unfortunately not collected any more. After participants discontinued with the randomized treatment, they were still followed to assess vital status, irrespective of the reason for discontinuation [13] .
Quality of life was assessed at baseline and subsequently every year with the KDQOL-SF version 1.3 (https://www. rand.org/content/dam/rand/pubs/papers/2006/P7994. pdf) [14, 15] For the present analyses we focused on the generic subscale PF. The 10 items the PF scale is composed of, are scored on a three point scale: 'not limited at all', 'limited a little' and 'limited a lot'. The score ranges from 0 to 100, with a higher score indicating a better health status.
Data analysis
Data were summarized using means with standard deviation (SD), medians with interquartile ranges, or proportions when appropriate. For age we a priori defined three groups (<65, 65-74 and ≥75 years old). The baseline HRQOL domain PF was categorized a priori into tertiles (a score of 0-33 was defined as 'low', 34-66 as 'intermediate' and 67-100 as 'good'). A 2-year outcome was defined as having one of the following five possible outcomes: either receiving a kidney transplant, death, improvement of PF score, equal PF score or decline of PF score. A difference in PF score of 5 points or more was considered as a clinically relevant change, as was proposed before [16] . Outcome differences between the three baseline PF tertiles and outcomes and between the age groups and outcomes were individually analyzed using chi-squared tests.
In addition, we analyzed the trajectory of the survivors, who had both baseline and follow-up data on PF available (n = 298). Change of PF score over a 2-year period was tested by means of paired sampled t-test. For the multivariate analysis we pre-defined the composite poor outcome 'decline of PF score ≥ 5 points or a PF < 33 points'. A combined end-point was chosen because we considered patients with a low PF score who did not show a further decline of PF score of ≥ 5 points, to have a poor clinical outcome nevertheless, as their PF level remained poor. A logistic regression model was used to assess the association between the composite outcome and baseline clinical and biochemical factors. The factors included demographics (age, sex), treatment related items (HD versus HDF, time on dialysis, residual renal function), BMI, systolic blood pressure, smoking, medical history (diabetes mellitus, coronary heart disease, cerebrovascular disease, peripheral artery disease) and laboratory results (hemoglobin, albumin, phosphate). A two-tailed P < 0.05 was considered statistically significant.
Results
Patient characteristics
The CONTRAST study included 714 patients of whom 95.1% completed the PF subdomain (Table 1) . Mean age was 64.1 (±13.7) years and 24.4% of the patients were ≥75 years old. Of all patients 62% were male. Median time on dialysis before entering the study, including both HD and PD, was 2 years (interquartile range 1-4 years). The percentage of patients in a good physical condition at baseline, as reflected by a PF score 67-100 points, was lower for increasing age groups: 41.7, 28.7 and 21.8%, respectively (P < 0.001).
Trajectories of PF
Of all patients with available follow-up data (72%), only 15.3% of patients had a good level of PF at baseline and was able to remain in at least the same physical condition over a period of 2 years (including a kidney transplantation). This was 25.1, 10.4 and 3.6% for the increasing age groups respectively (P < 0.001).
The influence of baseline physical condition on the trajectory of PF and mortality is shown in Figure 1 . A 2-year mortality rate was 14, 19 and 48% in patients with a good, intermediate and low baseline PF level, respectively (P < 0.001). Of the patients with a good baseline PF score, less than half (48%) remained in a good condition. Of the patients with a low PF score, 72% had a poor outcome within 2 years: in addition to the 48% mortality rate, 15% showed decline of PF score and 9% remained in the same poor condition.
As can be observed from Figure 2 , outcomes of patients aged ≥75 years were poor in general. Of the older patients with a poor PF at baseline more than halve (58%) died within 2 years. Of the older patients with a good baseline PF 42% deteriorated and 32% died. Thus, even in older patients with a good level of PF the vast majority (64%) had a poor outcome over a 2 years period. Of the youngest patients, 13.6% died and 25.1% showed decline of PF.
Overall, 19.8% of patients showed improvement of PF during follow-up. Improvement was most pronounced for patients <65 years old in a poor baseline condition (35.6%). Improvement rates did not differ significantly between the age groups (22.6, 18.8, 16.1% for increasing age groups, Values are means ± SD, median (interquartile range) or percentage. HDF, online hemodiafiltration; (low-flux) HD, hemodialysis; spKt/V urea single pool urea fractional clearance of body water of urea. a Residual kidney function if diuresis ≥100 ml/24 h. P = 0.296). Improvement of physical condition was more often seen in patients in an intermediate and poor condition (both 24.1% improvement) compared to those in a good condition (10.8%, P = 0.002).
Trajectory of PF over 2 years in survivors
The absolute change of PF was −4. 
Discussion
This analysis of CONTRAST extends previous longitudinal research on PF in hemodialysis patients using the KDQOL by assessing the influence of age in more depth. The present analyses illustrate the high prevalence of a poor physical condition of chronic dialysis patients and show PF declines with increasing age. In addition, we demonstrated a high risk of poor physical outcome over a 2-year time span: only one out of six patients maintained a good PF during a 2-year time window. For the eldest patients (≥75 years old), this applied only for 1 out of 25 patients. In addition, patients in a poor physical condition are at high risk of dying. As PF is an important aspect of quality of life, these results may aid in gaining a more realistic perspective of quality of life on dialysis which could be beneficial in the decision-making process of dialysis initiation. Figure 2 . Trajectory of physical functioning by age category and by baseline physical functioning.
In contrast to earlier reports [1, 8] , we found age to be of influence on the decline of PF in hemodialysis. A clinically relevant change of PF over a 2-year time span was only found for patients aged ≥75 years and patients aged 65-74 years, while patients ≤65 year, who were still alive after 2 years, had a stable PF. In addition, age was strongly and independently associated with the odds of having a poor physical outcome after a 2-year period. Mean age of the CONTRAST population was higher (64 ± 14) compared to previous research (HEMO 58 ± 14 years [1] , NECOSAD 59 ± 16 years [8] ) and the study was completed a decade later, which might explain these discrepancies.
Compared to the general population, mean baseline PF of dialysis patients was low across all age groups. Norm values for the general Dutch population are: 41-60 years 85 ± 22, 61-70 years 75 ± 27, >70 years 61 ± 31 (P < 0.001) [17] . Thus, in the general population the level of PF is around 1.5 times higher than in the chronic dialysis population. In a Dutch non-CKD cohort of 2042 healthy individuals aged 15-85 years from the Profile Database 2010 (www.profielstudie.nl), a gradual decline of PF was seen from the age of 50 years. In this cross-sectional database, individuals were categorized by age in groups of 5 years. The mean PF difference was −2.07 points per 5 years. In the CONTRAST hemodialysis population, a mean decline of PF of almost 5 points was found in the two-year followup period. In conclusion, baseline PF is not only poor compared to the general population, deterioration of PF is also faster. As ESKD patients treated with conservative therapy are generally older and more frail, one would expect a more pronounced decline in this group. However, so far no data are available of the trajectory of PF of patients treated with conservative therapy. This will be the subject of the 'Geriatric assessment in OLder patients starting Dialysis' (GOLD) Study, which is currently ongoing.
This analysis of CONTRAST has some limitations. First, there is a high level of attrition, due to mortality and kidney transplants. Consequently, our main analysis was performed in patients who were still alive after 2 years only. In addition, the present analyses were performed in prevalent dialysis patients, of whom 26% were randomized within 1 year of dialysis initiation. These aspects may impede the generalizability of the data to a cohort of ESKD patients in whom the decision to start dialysis has to be made. Second, self-reported data on quality of life in general or PF in specific may exclude patients with very poor functioning or visual impairment from the analysis. The fact that our data was derived from a clinical trial furthermore induces a potential selection bias towards higher PF. Therefore, the percentage of patients with impairment may even be underestimated compared to the general dialysis population. Third, the cut-off values for low (score 0-33), intermediate (score 34-66) and good (score 67-100) PF were chosen arbitrarily, to facilitate interpretation for the clinician. There are no validated classifications for good or poor PF available. The cut-off values we chose may be relatively high for the dialysis population when compared to the mean norm values mentioned before. Finally, the percentage of missing follow-up data for PF was large (21.7%). However, no difference in baseline PF was found between patients with and those without available follow-up data.
As our analyses show the majority of older dialysis patients have a poor PF or decline even further, it would be valuable to assess interventions that may improve PF or slow down decline. Besides age and albumin, no relations with poor physical outcome were found. Based on these analyses, no clear starting points for potential interventions could be indicated. Previous research showed physical condition may be amenable to interventions such as physical exercise in CKD and dialysis [10] . In addition, physical exercise may prevent falls, which occur frequently and are increasingly recognized as a factor preceding poor outcome in dialysis [18] . Although data in older dialysis patients are lacking, exercise interventions have been shown to improve mobility, gait speed and muscle strength in (non-CKD) older patients [19] . Although physical training has been recommended in multiple guidelines, implementation rate is poor [20] . Of special note is that patients in CONTRAST did not receive rehabilitation exercise. Whether improvement of PF will also improve overall quality of life and survival, should be subject of future research.
Conclusion
Frail and older patients and physicians frequently face the dilemma whether prolonging of life by means of dialysis initiation offsets the burden of dialysis [21, 22] . A better understanding of the trajectory of PF, including maintenance of the ability to perform basic ADL, may aid in creating realistic expectations about independence and quality of life on dialysis. Despite the challenges of describing the longitudinal measurements of PF, this analysis provides relevant information of the trajectory of PF in chronic dialysis.
The mean level of PF in dialysis patients in general was 1.5 times lower than in the general population, and decline was faster. We have shown that patients with a low PF score at baseline were more likely to die, while patients in a good physical condition were more likely to show decrease of PF. In addition, only a small amount of patients was able to maintain a good physical condition over a two-year time span. In addition to older age and lower level of albumin, no factors could be identified that relate to poor physical outcome. Identification of patients at risk of decline of PF will therefore be difficult. Despite this, the information retrieved from this study may contribute to the decision-making process concerning dialysis initiation and underlines the need for research on the added value of rehabilitation programs in older patients.
Key points
• In chronic hemodialysis, very few patients maintain a good physical condition over time.
• Of older dialysis patients (≥75 years) only 1 in 25 remained in a good clinical condition over a 2-year period.
• In older patients, physical performance is poor and decline is faster than in the healthy population.
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